Expert opinion on the prescription practice of topical calamine lotion for chronic urticaria and other dermatologic conditions in Indian clinical settings

Authors

  • Manjula S. Department of Medical Services, Micro Labs Limited, Bangalore, Karnataka, India
  • Krishna Kumar M. Department of Medical Services, Micro Labs Limited, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20240969

Keywords:

Skin diseases, Calamine, Chronic urticaria, Pruritus, Antihistamines

Abstract

Background: Calamine is suggested as a potentially effective treatment for skin exudation, itching, and rashes. However, there aren't many thorough analyses of the drug prescription patterns for treating urticaria in the Indian literature. This study aimed to gather expert opinions on the prescription practice of topical calamine lotion for chronic urticaria and other dermatologic conditions in Indian clinical settings.

Methods: The cross-sectional questionnaire-based survey, comprising 25 questions, gathered data regarding the prescription practice of topical calamine lotion for the management of chronic urticaria and other dermatological conditions.

Results: Of the 467 participants, 62% indicated that they would prescribe topical calamine lotion for pruritus management. About 39% of the participants preferred the cream formulation of the calamine lotion for treating diaper dermatitis in 11-25% of patients. About 76% of the respondents stated that they would recommend an oral antihistamine along with topical calamine lotion to treat chronic urticaria. For the treatment of pruritus, 44% of the participants preferred menthol in addition to calamine. Sixty-eight per cent of the respondents stated that approximately 5% of those with chronic urticaria need to be treated with calamine and tetrahydrocurcumin. Most specialists (69.38%) preferred using calamine lotion on 5-10% of patients with itchy skin conditions during pregnancy.

Conclusions: Experts recommend the topical calamine lotion for managing various skin conditions including pruritus and chronic urticaria. Specialists recommended it as a safe option for managing itchy skin conditions during pregnancy.

References

Henderson RL, Fleischer AB, Feldman SR. Allergists and dermatologists have far more expertise in caring for patients with urticaria than other specialists. J Am Acad Dermatol. 2000;43(6):1084-91.

Kaplan AP. Chronic urticaria: Pathogenesis and treatment. J Aller Clin Immunol. 2004;114(3):465-74.

Gonçalo M, Gimenéz‐Arnau A, Al‐Ahmad M, Ben‐Shoshan M, Bernstein JA, Ensina LF, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatol. 2021;184(2):226-36.

Prasad PS. Urticaria. IJDVL. 2001;67:11.

Calamine, pramoxind HCl lotion. Available at: https://fda.report/DailyMed/82c4cfaa-768e-4192-87c5-581ae35241e0. Accessed on 20 November 2023.

Maibach HI. Topical skin therapeutics. Arch Dermatol. 1985;121(10):1340.

Sulzberger MB, Witten VH. The Effect of Topically Applied Compound F in Selected Dermatoses. J Investigat Dermatol. 1952;19(2):101-2.

Souza AD, Strober BE. Principles of topical therapy. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, eds. Fitzpatrick's Dermatology in General Medicine. 8th ed. New York: McGraw Hill; 2012:214; 2643-51.

Meng YC, Fan JC, Bian WN. Effectiveness of calamine lotion as an adjunctive therapy to mometasone furoate ointment in the treatment of infant eczema: A retrospective study. Medicine. 2022; 101(35):e30237.

Sulzberger MB, Witten VH. The Effect of Topically Applied Compound F in Selected Dermatoses. J Investigat Dermatol. 1952;19(2):101-2.

Souza AD, Strober BE. Principles of topical therapy. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, eds. Fitzpatrick’s Dermatology in General Medicine. 8th ed. New York: McGraw-Hill; 2012.

Dixit S, Jain A, Datar S, Khurana VK. Congenital miliaria crystallina: A diagnostic dilemma. Med J Arm Forces India. 2012;68(4):386-8.

Teixeira A, Teixeira M, Almeida V, Gaio R, Torres T, Magina S, et al. Does the vehicle matter? Real-world evidence on adherence to topical treatment in psoriasis. Pharmaceutics. 2021;13(10):1539.

Eastman WJ, Malahias S, Delconte J, DiBenedetti D. Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis. Cutis. 2014;94(1):46-53.

Tang X, Dong Q, Li J, Li F, Michniak-Kohn BB, Zhao D, et al. Anti-melanogenic mechanism of tetrahydrocurcumin and enhancing its topical delivery efficacy using a lecithin-based nanoemulsion. Pharmaceutics. 2021;13(8):1185.

Downloads

Published

2024-04-24

Issue

Section

Original Research Articles